Featured
What is the optimal duration of maintenance in myeloma?
SAN FRANCISCO – Should patients with multiple myeloma receive maintenance therapy until progression?
Latest News
October 17, 2019
Veliparib improves PFS in high-grade serous epithelial ovarian cancer
October 17, 2019
MDedge Hematology and Oncology
October 16, 2019
Universal coverage may be possible without increases in national spending
October 16, 2019
MDedge Hematology and Oncology
October 16, 2019
Health care stayed front and center at Democratic debate
October 16, 2019
MDedge Hematology and Oncology
From the Editor
Dr. Matt Kalaycio tackles challenges in academic leadership and current controversies in the specialty.
Hard Questions
Dr. Ilana Yurkiewicz explores the human side of hematology, sharing patient encounters in her hem-onc fellowship.
How I Will Treat My Next Patient
Dr. Alan Lyss breaks down the latest study findings into practice-changing tips.
Conference Coverage
October 17, 2019
Veliparib improves PFS in high-grade serous epithelial ovarian cancer
October 17, 2019
MDedge Hematology and Oncology
October 16, 2019
PJP prophylaxis may be unnecessary for CLL patients on BTK inhibitors
October 16, 2019
MDedge Hematology and Oncology
October 14, 2019
Nivolumab boosts overall survival in HCC
October 14, 2019
MDedge Hematology and Oncology
Drug Approvals
October 15, 2019
FDA approves rivaroxaban for VTE prevention in hospitalized, acutely ill patients
October 15, 2019
MDedge Hematology and Oncology
September 26, 2019
Daratumumab approved in combo with VTd for transplant-eligible multiple myeloma
September 26, 2019
MDedge Hematology and Oncology
September 26, 2019
CDC awards $1.2 million to learn about people with sickle cell disease
September 26, 2019
MDedge Hematology and Oncology
September 17, 2019
FDA approves pembrolizumab/lenvatinib combo for advanced endometrial carcinoma
September 17, 2019
MDedge Hematology and Oncology
Policy & Practice
October 16, 2019
Universal coverage may be possible without increases in national spending
October 16, 2019
MDedge Hematology and Oncology
October 16, 2019
Health care stayed front and center at Democratic debate
October 16, 2019
MDedge Hematology and Oncology
October 15, 2019
Uninsured population is big in Texas
October 15, 2019
MDedge Hematology and Oncology
October 15, 2019
Bringing focus to the issue: Dr. Elizabeth Loder on gender in medicine
October 15, 2019
MDedge Hematology and Oncology
Opinion
September 30, 2019
Labeling of medication warnings
September 30, 2019
MDedge Hematology and Oncology
